Haihua Qian

1.1k total citations
29 papers, 828 citations indexed

About

Haihua Qian is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Haihua Qian has authored 29 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Haihua Qian's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Haihua Qian is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Haihua Qian collaborates with scholars based in China, Serbia and United Kingdom. Haihua Qian's co-authors include Bin Sun, Weidan Ji, Changqing Su, Yan Yan, Mengchao Wu, Xianshuo Cheng, Zhibin Yang, Shuwen Shen, Xiaofeng Zhang and Zhengfeng Yin and has published in prestigious journals such as PLoS ONE, Cancer Letters and Medicine.

In The Last Decade

Haihua Qian

29 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haihua Qian China 17 500 311 261 140 100 29 828
Shucai Yang China 13 509 1.0× 317 1.0× 230 0.9× 154 1.1× 95 0.9× 24 793
Xiaoqian Jing China 19 442 0.9× 221 0.7× 185 0.7× 105 0.8× 94 0.9× 32 680
Zhibin Liao China 21 794 1.6× 468 1.5× 181 0.7× 85 0.6× 100 1.0× 47 1.0k
Guangshun Sun China 16 478 1.0× 271 0.9× 230 0.9× 168 1.2× 120 1.2× 27 790
Zhouyu Ning China 19 500 1.0× 357 1.1× 364 1.4× 87 0.6× 134 1.3× 40 911
Şerif Şentürk Türkiye 16 796 1.6× 246 0.8× 295 1.1× 122 0.9× 101 1.0× 38 1.2k
Xiaopeng Cui China 17 470 0.9× 244 0.8× 137 0.5× 77 0.6× 75 0.8× 35 676
Russell Ericksen United States 14 523 1.0× 271 0.9× 305 1.2× 144 1.0× 115 1.1× 22 1.0k
Liangliang Ren China 22 823 1.6× 467 1.5× 191 0.7× 80 0.6× 206 2.1× 43 1.1k
Galina M. Kiriakova United States 10 380 0.8× 210 0.7× 310 1.2× 169 1.2× 56 0.6× 11 707

Countries citing papers authored by Haihua Qian

Since Specialization
Citations

This map shows the geographic impact of Haihua Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haihua Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haihua Qian more than expected).

Fields of papers citing papers by Haihua Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haihua Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haihua Qian. The network helps show where Haihua Qian may publish in the future.

Co-authorship network of co-authors of Haihua Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Haihua Qian. A scholar is included among the top collaborators of Haihua Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haihua Qian. Haihua Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiali, et al.. (2024). Global trends in colorectal cancer and metabolic syndrome research: a bibliometric and visualization analysis. International Journal of Surgery. 110(6). 3723–3733. 9 indexed citations
2.
Wei, Yanping, Hailing Zhang, Yan Ling, et al.. (2023). N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes. iScience. 26(10). 108022–108022. 12 indexed citations
3.
Lv, Lei, et al.. (2023). Role of antibiotics in Milligan-Morgan hemorrhoidectomy for Grade III to IV Hemorrhoids: A randomized clinical trial. Asian Journal of Surgery. 47(1). 169–175. 1 indexed citations
4.
Li, Qing, Li Li, Heng Zhang, et al.. (2022). Correlation Between Poor Defecation Habits and Postoperative Hemorrhoid Recurrence. Frontiers in Surgery. 9. 930215–930215. 3 indexed citations
5.
Zhang, Dan, Ting Xing, Meiyu Zhou, et al.. (2022). Intra and inter: Alterations in functional brain resting-state networks in patients with functional constipation. Frontiers in Neuroscience. 16. 957620–957620. 4 indexed citations
6.
Yan, Shuai, Yinzi Yue, Mingming Sun, et al.. (2021). Comparative Transcriptome Analysis Reveals Relationship among mRNAs, lncRNAs, and circRNAs of Slow Transit Constipation. BioMed Research International. 2021(1). 6672899–6672899. 3 indexed citations
7.
Zhang, Dan, et al.. (2021). STAT6 rs324015 Gene Polymorphism Increases Ulcerative Colitis Risk: A Case–Control Study. Pharmacogenomics and Personalized Medicine. Volume 14. 101–107. 4 indexed citations
8.
Zhou, Xi, Haihua Qian, Dan Zhang, & Li Zeng. (2020). Garlic intake and the risk of colorectal cancer. Medicine. 99(1). e18575–e18575. 17 indexed citations
9.
Chang, Shu‐Chen, Guangli Sun, Dan Zhang, Qing Li, & Haihua Qian. (2020). MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Cell Death and Disease. 11(7). 592–592. 16 indexed citations
10.
Zhang, Qin, et al.. (2020). Enrichment and identification of differentially expressed genes in hepatocellular carcinoma stem‑like cells. Oncology Letters. 20(6). 1–1. 1 indexed citations
11.
Yin, Haisen, Risheng Que, Chunying Liu, et al.. (2018). Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma. Cancer Letters. 425. 54–64. 42 indexed citations
12.
Yang, Zhibin, Xianshuo Cheng, Tao Shen, et al.. (2015). CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis. Cancer Letters. 361(1). 22–32. 80 indexed citations
13.
Qian, Haihua, et al.. (2015). Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis. Clinica Chimica Acta. 451(Pt B). 208–214. 28 indexed citations
14.
15.
Yan, Yan, Can Xu, Weidan Ji, et al.. (2013). MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Letters. 337(2). 226–236. 155 indexed citations
16.
Sun, Bin, Xiaofeng Zhang, Xianshuo Cheng, et al.. (2013). Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma. PLoS ONE. 8(11). e80212–e80212. 21 indexed citations
17.
Cao, Lu, Chunguang Li, Shuwen Shen, et al.. (2013). OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer. 13(1). 82–82. 70 indexed citations
18.
Li, Chun Guang, Yan Yan, Weidan Ji, et al.. (2012). OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma. PLoS ONE. 7(11). e49693–e49693. 65 indexed citations
19.
Ji, Weidan, Jiahe Yang, Lu Cao, et al.. (2011). hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers. PLoS ONE. 6(8). e23274–e23274. 25 indexed citations
20.
Zhou, Yanming, et al.. (2008). Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells. World Journal of Gastroenterology. 14(14). 2168–2168. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shucai Yang Breakdown of academic impact, for papers by Xiaoqian Jing Breakdown of academic impact, for papers by Zhibin Liao Breakdown of academic impact, for papers by Guangshun Sun Breakdown of academic impact, for papers by Zhouyu Ning Breakdown of academic impact, for papers by Şerif Şentürk Breakdown of academic impact, for papers by Xiaopeng Cui Breakdown of academic impact, for papers by Russell Ericksen Breakdown of academic impact, for papers by Liangliang Ren Breakdown of academic impact, for papers by Galina M. Kiriakova
Rankless by CCL
2026